Home Home Erika U. Augustine, M.D.

Erika U. Augustine, M.D.

Contact

Appointment (585) 275-2808

Fax (585) 275-3683

About Me
Credentials
Research
Publications
Locations

About Me

Faculty Appointments

Adjunct Associate Professor - Department of Neurology, Child Neurology (SMD)

Credentials

Post-doctoral Training & Residency

Experimental Therapeutics Fellow, Neurology, University of Rochester 2008 - 2010

Pediatric Movement Disorders Fellow, Child Neurology, University of Rochester 2008 - 2010

Chief Resident, Child Neurology, Children's Hospital Boston 2007 - 2008

Resident, Child Neurology, Children's Hospital Boston 2005 - 2007

Resident, Pediatrics, Boston Combined Residency Program in Pediatrics 2004 - 2005

Intern, Pediatrics, Boston Combined Residency Program in Pediatrics 2003 - 2004

Education

MD | University of Rochester School of Medicine & Dentistry. Medicine. 2003

BA | Harvard University. Biological Anthropology. 1999

Awards

Neurology Junior Faculty Teaching Award. 2013

Travel Grant. 2009

Pediatric Epilepsy Seminar Scholarship. 2007

American Neurological Association Residents' Program Scholarship. 2007

Alpha Omega Alpha. 2003

Dean's Fellowship. 1999 - 2003

Research

Patents

Neruonal Ceroid Lipofuscinosis (NCL) Study Group Unified Batten Disease Rating Scale

Issue date: January 21, 2020

Neuronal Ceroid Lipofuscinosis Study Group Demographics/Diagnostics/Medical History

Issue date: January 21, 2020

Neuronal Ceroid Lipofuscinosis Study Group Review of Symptoms

Issue date: January 21, 2020

Publications

Journal Articles

Anxiety Symptoms Differ in Youth With and Without Tic Disorders.

Vermilion J, Pedraza C, Augustine EF, Adams HR, Vierhile A, Lewin AB, Collins AT, McDermott MP, O'Connor T, Kurlan R, van Wijngaarden E, Murphy TK, Mink JW

Child psychiatry and human development.. 2021 April 52 (2):301-310. Epub 1900 01 01.

Pediatric Neurology Research in the Twenty-First Century: Status, Challenges, and Future Directions Post-COVID-19.

Bonkowsky JL, deVeber G, Kosofsky BE,

Pediatric neurology.. 2020 December 113 :2-12. Epub 08/26/2020.

Batten disease: an expert update on agents in preclinical and clinical trials.

Masten MC, Mink JW, Augustine EF

Expert opinion on investigational drugs.. 2020 December 29 (12):1317-1322. Epub 11/01/2020.

The CLN3 Disease Staging System: A new tool for clinical research in Batten disease.

Masten MC, Williams JD, Vermilion J, Adams HR, Vierhile A, Collins A, Marshall FJ, Augustine EF, Mink JW

Neurology.. 2020 June 994 (23):e2436-e2440. Epub 04/16/2020.

Deep Phenotyping of Parkinson's Disease.

Dorsey ER, Omberg L, Waddell E, Adams JL, Adams R, Ali MR, Amodeo K, Arky A, Augustine EF, Dinesh K, Hoque ME, Glidden AM, Jensen-Roberts S, Kabelac Z, Katabi D, Kieburtz K, Kinel DR, Little MA, Lizarraga KJ, Myers T, Riggare S, Rosero SZ, Saria S, Schifitto G, Schneider RB, Sharma G, Shoulson I, Stevenson EA, Tarolli CG, Luo J, McDermott MP

Journal of Parkinson's disease.. 2020 10 (3):855-873. Epub 1900 01 01.

A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson's Disease: Study Protocol and Design.

Schneider RB, Myers TL, Rowbotham HM, Luff MK, Amodeo K, Sharma S, Wilson R, Jensen-Roberts S, Auinger P, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Cannon P, , Holloway RG, Dorsey ER

Journal of Parkinson's disease.. 2020 10 (3):1195-1207. Epub 1900 01 01.

Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease.

Kim J, Hu C, Moufawad El Achkar C, Black LE, Douville J, Larson A, Pendergast MK, Goldkind SF, Lee EA, Kuniholm A, Soucy A, Vaze J, Belur NR, Fredriksen K, Stojkovska I, Tsytsykova A, Armant M, DiDonato RL, Choi J, Cornelissen L, Pereira LM, Augustine EF, Genetti CA, Dies K, Barton B, Williams L, Goodlett BD, Riley BL, Pasternak A, Berry ER, Pflock KA, Chu S, Reed C, Tyndall K, Agrawal PB, Beggs AH, Grant PE, Urion DK, Snyder RO, Waisbren SE, Poduri A, Park PJ, Patterson A, Biffi A, Mazzulli JR, Bodamer O, Berde CB, Yu TW

The New England journal of medicine.. 2019 October 24381 (17):1644-1652. Epub 10/09/2019.

A novel, hybrid, single- and multi-site clinical trial design for CLN3 disease, an ultra-rare lysosomal storage disorder.

Adams HR, Defendorf S, Vierhile A, Mink JW, Marshall FJ, Augustine EF

Clinical trials : journal of the Society for Clinical Trials.. 2019 October 16 (5):555-560. Epub 06/11/2019.

Clinical pearls and scientific advancement: Reconciling tradition with new knowledge.

Augustine EF, Gilbert DL

Neurology.. 2017 May 988 (19):1786-1787. Epub 04/07/2017.

Design of a Multisite Study Assessing the Impact of Tic Disorders on Individuals, Families, and Communities.

Augustine EF, Adams HR, Bitsko RH, van Wijngaarden E, Claussen AH, Thatcher A, Hanks CE, Lewin AB, O'Connor TG, Vierhile A, Danielson ML, Kurlan R, Murphy TK, Mink JW

Pediatric neurology.. 2017 March 68 :49-58.e3. Epub 11/08/2016.

Communicating with participants during the conduct of multi-center clinical trials.

Augustine EF, Dorsey ER, Hauser RA, Elm JJ, Tilley BC, Kieburtz KK

Clinical trials : journal of the Society for Clinical Trials.. 2016 December 13 (6):592-596. Epub 08/29/2016.

Delineation of the movement disorders associated with FOXG1 mutations.

Papandreou A, Schneider RB, Augustine EF, Ng J, Mankad K, Meyer E, McTague A, Ngoh A, Hemingway C, Robinson R, Varadkar SM, Kinali M, Salpietro V, O'Driscoll MC, Basheer SN, Webster RI, Mohammad SS, Pula S, McGowan M, Trump N, Jenkins L, Elmslie F, Scott RH, Hurst JA, Perez-Duenas B, Paciorkowski AR, Kurian MA

Neurology.. 2016 May 1086 (19):1794-800. Epub 03/30/2016.

Remote Assessment of Cognitive Function in Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease): A Pilot Study of Feasibility and Reliability.

Ragbeer SN, Augustine EF, Mink JW, Thatcher AR, Vierhile AE, Adams HR

Journal of child neurology.. 2016 March 31 (4):481-7. Epub 09/02/2015.

SUICIDAL THOUGHTS AND BEHAVIORS IN CHILDREN AND ADOLESCENTS WITH CHRONIC TIC DISORDERS.

Storch EA, Hanks CE, Mink JW, McGuire JF, Adams HR, Augustine EF, Vierhile A, Thatcher A, Bitsko R, Lewin AB, Murphy TK

Depression and anxiety.. 2015 October 32 (10):744-53. Epub 02/24/2015.

Neonatal dentate nucleus T2 hyperintensity after in utero metronidazole exposure.

Bates JE, Almast J, Augustine EF

Neurology.. 2015 September 1585 (11):1006. Epub 1900 01 01.

Standardized assessment of seizures in patients with juvenile neuronal ceroid lipofuscinosis.

Augustine EF, Adams HR, Beck CA, Vierhile A, Kwon J, Rothberg PG, Marshall F, Block R, Dolan J, Mink JW,

Developmental medicine and child neurology.. 2015 April 57 (4):366-71. Epub 11/11/2014.

Immunosuppressive Treatment for Retinal Degeneration in Juvenile Neuronal Ceroid Lipofuscinosis (Juvenile Batten Disease).

Drack AV, Mullins RF, Pfeifer WL, Augustine EF, Stasheff SF, Hong SD

Ophthalmic genetics.. 2015 36 (4):359-64. Epub 02/19/2014.

Sex Differences in Clinical Features of Early, Treated Parkinson's Disease.

Augustine EF, Pérez A, Dhall R, Umeh CC, Videnovic A, Cambi F, Wills AA, Elm JJ, Zweig RM, Shulman LM, Nance MA, Bainbridge J, Suchowersky O

PloS one.. 2015 10 (7):e0133002. Epub 07/14/2015.

Pearls & Oy-sters: cough headache secondary to Chiari malformation type I.

Bates JE, Augustine EF

Neurology.. 2014 October 1483 (16):e149-51. Epub 1900 01 01.

Utility of the diagnostic interview schedule for children for assessing Tourette syndrome in children.

Lewin AB, Mink JW, Bitsko RH, Holbrook JR, Parker-Athill EC, Hanks C, Storch EA, Augustine EF, Adams HR, Vierhile AE, Thatcher AR, Murphy TK

Journal of child and adolescent psychopharmacology.. 2014 June 24 (5):275-84. Epub 05/09/2014.

Experience, knowledge, and opinions about childhood genetic testing in Batten disease.

Adams HR, Rose K, Augustine EF, Kwon JM, Deblieck EA, Marshall FJ, Vierhile A, Mink JW, Nance MA

Molecular genetics and metabolism.. 2014 February 111 (2):197-202. Epub 11/04/2013.

Malignant melanoma in early-treated Parkinson's disease: the NET-PD trial.

Constantinescu R, Elm J, Auinger P, Sharma S, Augustine EF, Khadim L, Kieburtz K,

Movement disorders : official journal of the Movement Disorder Society.. 2014 February 29 (2):263-5. Epub 12/03/2013.

No sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada - baseline findings of a multicenter trial.

Umeh CC, Pérez A, Augustine EF, Dhall R, Dewey RB, Mari Z, Simon DK, Wills AM, Christine CW, Schneider JS, Suchowersky O

PloS one.. 2014 9 (12):e112287. Epub 12/08/2014.

Enzyme replacement in neuronal storage disorders in the pediatric population.

Augustine EF, Mink JW

Current treatment options in neurology.. 2013 October 15 (5):634-51. Epub 1900 01 01.

Classification and natural history of the neuronal ceroid lipofuscinoses.

Mink JW, Augustine EF, Adams HR, Marshall FJ, Kwon JM

Journal of child neurology.. 2013 September 28 (9):1101-5. Epub 07/09/2013.

Clinical trials in rare disease: challenges and opportunities.

Augustine EF, Adams HR, Mink JW

Journal of child neurology.. 2013 September 28 (9):1142-50. Epub 1900 01 01.

Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates.

de Blieck EA, Augustine EF, Marshall FJ, Adams H, Cialone J, Dure L, Kwon JM, Newhouse N, Rose K, Rothberg PG, Vierhile A, Mink JW,

Contemporary clinical trials.. 2013 July 35 (2):48-54. Epub 04/26/2013.

Myoclonus-dystonia syndrome associated with Russell Silver syndrome.

Augustine EF, Blackburn J, Pellegrino JE, Miller R, Mink JW

Movement disorders : official journal of the Movement Disorder Society.. 2013 June 28 (6):841-2. Epub 05/23/2013.

Pediatric movement disorders: Five new things.

Blackburn JS, Mink JW, Augustine EF

Neurology. Clinical practice.. 2012 December 2 (4):311-318. Epub 1900 01 01.

Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1.

Elm JJ,

Movement disorders : official journal of the Movement Disorder Society.. 2012 October 27 (12):1513-21. Epub 1900 01 01.

Emerging subspecialties in neurology: fellowship in experimental therapeutics of neurologic disease.

Statland JM, Griggs RC, Augustine EF

Neurology.. 2012 September 2579 (13):e106-8. Epub 1900 01 01.

Females experience a more severe disease course in Batten disease.

Cialone J, Adams H, Augustine EF, Marshall FJ, Kwon JM, Newhouse N, Vierhile A, Levy E, Dure LS, Rose KR, Ramirez-Montealegre D, de Blieck EA, Mink JW

Journal of inherited metabolic disease.. 2012 May 35 (3):549-55. Epub 12/14/2011.

Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease).

Kwon JM, Adams H, Rothberg PG, Augustine EF, Marshall FJ, Deblieck EA, Vierhile A, Beck CA, Newhouse NJ, Cialone J, Levy E, Ramirez-Montealegre D, Dure LS, Rose KR, Mink JW

Neurology.. 2011 November 1577 (20):1801-7. Epub 10/19/2011.

Quantitative telemedicine ratings in Batten disease: implications for rare disease research.

Cialone J, Augustine EF, Newhouse N, Vierhile A, Marshall FJ, Mink JW

Neurology.. 2011 November 1577 (20):1808-11. Epub 10/19/2011.

Parent-reported benefits of flupirtine in juvenile neuronal ceroid lipofuscinosis (Batten disease; CLN3) are not supported by quantitative data.

Cialone J, Augustine EF, Newhouse N, Adams H, Vierhile A, Marshall FJ, de Blieck EA, Kwon J, Rothberg PG, Mink JW

Journal of inherited metabolic disease.. 2011 October 34 (5):1075-81. Epub 05/10/2011.

Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (Batten disease).

Adams HR, Beck CA, Levy E, Jordan R, Kwon JM, Marshall FJ, Vierhile A, Augustine EF, DE Blieck EA, Pearce DA, Mink JW

Developmental medicine and child neurology.. 2010 July 52 (7):637-43. Epub 02/19/2010.

Masturbation in infancy and early childhood presenting as a movement disorder: 12 cases and a review of the literature.

Yang ML, Fullwood E, Goldstein J, Mink JW